Trials that use: Multiplicity adjustment
New to this method? Read the tutorial →
20,317 results
- ScanBritIndependent statistical analysis of ScanBrit Dietary Intervention in Autism: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00614198).
- SCANREP: Reliability of 3D Lower Limb Scanning: Complete Statistical AnalysisIndependent statistical analysis of SCANREP: Reliability of 3D Lower Limb Scanning: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04032041).
- Scar Appearance After Postoperative Hydrocolloid Dressing Versus Standard Petrolatum Ointment: Complete Statistical AnalysisIndependent statistical analysis of Scar Appearance After Postoperative Hydrocolloid Dressing Versus Standard Petrolatum Ointment: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05618912).
- Scavenging of Reactive Carbonyl Species by Apple Polyphenols in Human: Complete Statistical AnalysisIndependent statistical analysis of Scavenging of Reactive Carbonyl Species by Apple Polyphenols in Human: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03911050).
- SCD PED-02Independent statistical analysis of A Multi-Center Study of a SCD for Immunomodulatory Dysregulation in Pediatric AKI: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- SCD-PED-01Independent statistical analysis of Safety and Efficacy of a Selective Cytopheretic Device (SCD) in Pediatric Patients With Acute Kidney Injury (AKI).: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- SCENTIndependent statistical analysis of Smell Changes & Efficacy of Nasal Theophylline: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03990766).
- SCENT2Independent statistical analysis of Smell in Covid-19 and Efficacy of Nasal Theophylline: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04789499).
- SCH 54031 PEG12000 Interferon Alfa-2b (PEG Intron, MK-4031) vs. INTRON®A (SCH 30500, MK-2958) as Adjuvant Therapy for Melanoma (C98-135, MK-4031-002): Complete Statistical AnalysisIndependent statistical analysis of SCH 54031 PEG12000 Interferon Alfa-2b (PEG Intron, MK-4031) vs. INTRON®A (SCH 30500, MK-2958) as Adjuvant Therapy for Melanoma (C98-135, MK-4031-002): primary endpoint results, effect estimate with confidence interval,…
- SCHEARLYIndependent statistical analysis of A Study of the Safety of Subcutaneously Administered Trastuzumab (Herceptin) in Participants With Early and Locally Advanced Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Breast Cancer: primary endpoint…
- School-Based Mental Health Effectiveness Study: Complete Statistical AnalysisIndependent statistical analysis of School-Based Mental Health Effectiveness Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04383327).
- SCI Acute Intermittent Hypoxia and Non-Invasive Spinal Stimulation Combined With Gait Training: Complete Statistical AnalysisIndependent statistical analysis of SCI Acute Intermittent Hypoxia and Non-Invasive Spinal Stimulation Combined With Gait Training: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- SCIALEROIndependent statistical analysis of Regional Anesthesia for Major Surgery of the Foot. Levobupivacaïne Ropivacaine 0.5% Versus 0.5% in the Sciatic Block Through médiofémorale: primary endpoint results, effect estimate with confidence interval, sample-size…
- SCIENCEIndependent statistical analysis of Spinal Cord Injury Exercise and Nutrition Conceptual Engagement: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03495986).
- SCIP-PAIndependent statistical analysis of Tailored Intervention to Promote Positive Airway Pressure Adherence: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01454830).
- SCIPHSIndependent statistical analysis of Impact of Passive Heat on Metabolic, Inflammatory and Vascular Health in Persons With Spinal Cord Injury: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- SCITMOIndependent statistical analysis of Subcutaneous Immunotherapy for Mouse in Adults: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02532179).
- SclerodermaIndependent statistical analysis of Systemic Sclerosis (SSc) Vasculopathy: Improved Clinical Monitoring and Treatment: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02530996).
- SCLUJamaicaIndependent statistical analysis of Test of the Safety, Effectiveness, & Acceptability of An Improvised Dressing for Sickle Cell Leg Ulcers in the Tropics: primary endpoint results, effect estimate with confidence interval, sample-size…
- SCMSUDIndependent statistical analysis of Contingency Management for Smoking in Substance Abusers: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00807742).
- SCNSL1Independent statistical analysis of High-dose Sequential Chemoimmunotherapy for B-cell Lymphomas With Central Nervous System Involvement: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- SCOBA-PHIndependent statistical analysis of Safely Change From Bosentan to Ambrisentan in Pulmonary Hypertension: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01330108).
- SCOPE-BDIndependent statistical analysis of Scopolamine in Bipolar Depression: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04211961).
- SCOREIndependent statistical analysis of Sonu Nasal Congestion Relief Study in Patients Suffering From Moderate to Severe Nasal Congestion: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- SCOREDIndependent statistical analysis of Effect of Sotagliflozin on Cardiovascular and Renal Events in Participants With Type 2 Diabetes and Moderate Renal Impairment Who Are at Cardiovascular Risk: primary endpoint results, effect estimate…
- Scoring Clinical Index For Onychomycosis in Toenail Onychomycosis Treating With Itraconazole Capsules: Complete Statistical AnalysisIndependent statistical analysis of Scoring Clinical Index For Onychomycosis in Toenail Onychomycosis Treating With Itraconazole Capsules: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- SCORPIOComplete statistical analysis of the SCORPIO phase 3 trial of mirabegron in patients with symptoms of overactive bladder, including endpoint definitions, ANCOVA methodology, efficacy results, multiplicity, missing-data handling, and safety.
- SCORPIO-PEPIndependent statistical analysis of Phase 3 Study of S-217622 in Prevention of Symptomatic SARS-CoV-2 Infection: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- ScorpioNRGPSIndependent statistical analysis of Scorpio Posterior Stabilised (PS) vs Scorpio NRG ("Energize") PS - Total Knee Arthroplasty: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- SCOTIndependent statistical analysis of Scleroderma: Cyclophosphamide or Transplantation: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00114530).
- SCOUTSIndependent statistical analysis of Stroke and CPAP Outcome Study: A Sham-controlled Trial of CPAP Among Stroke Rehabilitation Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- SCOUTS3Independent statistical analysis of Stroke and CPAP Outcome Study 3: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT06029959).
- SCP® Observational Study of the Knee: Complete Statistical AnalysisIndependent statistical analysis of SCP® Observational Study of the Knee: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03110224).
- Scrambler Trial for Pain in NMOSD: Complete Statistical AnalysisIndependent statistical analysis of Scrambler Trial for Pain in NMOSD: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03452176).
- SCRATCH-ADIndependent statistical analysis of The Purpose of the Study is to Evaluate the Effect of Ruxolitinib Cream on Itch in Participants With Atopic Dermatitis: primary endpoint results, effect estimate with confidence interval,…
- Screening and Brief Advice to Reduce Teen Substance Use: Complete Statistical AnalysisIndependent statistical analysis of Screening and Brief Advice to Reduce Teen Substance Use: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00227877).
- Screening Wizard- Phase 2: Complete Statistical AnalysisIndependent statistical analysis of Screening Wizard- Phase 2: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04646369).
- SCS-90Independent statistical analysis of Spinal Cord Stimulation for Restoration of Function in Lower-Limb Amputees, 90-Day: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- SCSSIndependent statistical analysis of Sublingual Cockroach Safety in Adults With Cockroach Allergy & Perennial Allergic Rhinitis With or Without Asthma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- SCT&DVTIndependent statistical analysis of Sickle Cell Trait and the Risk of Venous Thromboembolism: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01148940).
- Sculptra for Correction of Midface Volume Deficit and/or Midface Contour Deficiency: Complete Statistical AnalysisIndependent statistical analysis of Sculptra for Correction of Midface Volume Deficit and/or Midface Contour Deficiency: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- SCYNERGIAIndependent statistical analysis of Evaluate Safety and Efficacy of the Coadministration of Ibrexafungerp With Voriconazole in Patients With Invasive Pulmonary Aspergillosis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- SD-VTSIndependent statistical analysis of Laryngeal Vibration for Spasmodic Dysphonia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03746509).
- SDFCIndependent statistical analysis of Olfactory Contributions to Sleep-dependent Food Craving: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04179838).
- SDHDSIndependent statistical analysis of The Effect of Spironolactone on Blood Pressure in Type-2 Diabetics With Resistant Hypertension: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- SDM-LCS-SCIndependent statistical analysis of Shared Decision Making in Rural Primary Care Lung Cancer Screening and Smoking Cessation: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- SDM4IPIndependent statistical analysis of Implementing Shared Decision Making (SDM) For Individualized CV Prevention (SDM4IP): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04450914).
- SDOHIndependent statistical analysis of Social Determinants of Health Screening and Interventions: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03661359).
- SDPTSDIndependent statistical analysis of Can Service Dogs Improve Activity and Quality of Life in Veterans With PTSD?: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- SDTTIndependent statistical analysis of Assessment of Laryngopharyngeal Sensation in Adductor Spasmodic Dysphonia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05158179).